DE2635508A1 - Antiseptischer verband - Google Patents
Antiseptischer verbandInfo
- Publication number
- DE2635508A1 DE2635508A1 DE19762635508 DE2635508A DE2635508A1 DE 2635508 A1 DE2635508 A1 DE 2635508A1 DE 19762635508 DE19762635508 DE 19762635508 DE 2635508 A DE2635508 A DE 2635508A DE 2635508 A1 DE2635508 A1 DE 2635508A1
- Authority
- DE
- Germany
- Prior art keywords
- film
- protein
- hypochlorite
- forming
- reaction product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002421 anti-septic effect Effects 0.000 title claims description 11
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 claims description 56
- 102000004169 proteins and genes Human genes 0.000 claims description 35
- 108090000623 proteins and genes Proteins 0.000 claims description 35
- 239000007795 chemical reaction product Substances 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 18
- 239000008273 gelatin Substances 0.000 claims description 18
- 229920000159 gelatin Polymers 0.000 claims description 18
- 235000019322 gelatine Nutrition 0.000 claims description 18
- 235000011852 gelatine desserts Nutrition 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 230000002787 reinforcement Effects 0.000 claims description 11
- 241001465754 Metazoa Species 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 102000009123 Fibrin Human genes 0.000 claims description 4
- 108010073385 Fibrin Proteins 0.000 claims description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 4
- 229950003499 fibrin Drugs 0.000 claims description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229960005188 collagen Drugs 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 229940014259 gelatin Drugs 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 26
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 230000035876 healing Effects 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 3
- 229940064004 antiseptic throat preparations Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 3
- NHYCGSASNAIGLD-UHFFFAOYSA-N Chlorine monoxide Chemical compound Cl[O] NHYCGSASNAIGLD-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000876435 Hucho hucho Species 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- -1 alkali metal hypochlorite Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- LWXVCCOAQYNXNX-UHFFFAOYSA-N lithium hypochlorite Chemical compound [Li+].Cl[O-] LWXVCCOAQYNXNX-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/602,410 US4035483A (en) | 1973-05-29 | 1975-08-06 | Antiseptic and non-toxic substance and a method of making the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2635508A1 true DE2635508A1 (de) | 1977-02-10 |
Family
ID=24411229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762635508 Withdrawn DE2635508A1 (de) | 1975-08-06 | 1976-08-06 | Antiseptischer verband |
Country Status (15)
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4204992A (en) | 1977-08-29 | 1980-05-27 | Avicon, Inc. | Method for preparing pyrogen free collagen |
US4363322A (en) | 1978-04-13 | 1982-12-14 | Andersson A E Bror | Deodorizing and disinfecting liquid-absorbing product and process for production thereof |
WO1984001108A1 (en) * | 1982-09-14 | 1984-03-29 | Magnus Hoeoek | Means for removing microorganisms from tissue |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1104127A (en) * | 1977-08-29 | 1981-06-30 | Mamerto M. Cruz, Jr. | Method for preparing pyrogen free collagen |
US4986990A (en) * | 1984-03-21 | 1991-01-22 | Alcide Corporation | Disinfection method and composition therefor |
US5185161A (en) * | 1984-03-21 | 1993-02-09 | Alcide Corporation | Disinfection method and composition therefor |
DE3515745A1 (de) * | 1985-05-02 | 1986-11-06 | Oxo Chemie GmbH, 6900 Heidelberg | Waessrige chloritmatrix-loesung |
US4737307A (en) * | 1986-09-18 | 1988-04-12 | Brown Robert L | Skin cleanser capable of removing smegma and surface bacteria, fungus and viruses from surface of skin |
US4891216A (en) * | 1987-04-14 | 1990-01-02 | Alcide Corporation | Disinfecting compositions and methods therefor |
US4927641A (en) * | 1989-05-23 | 1990-05-22 | Knight Gerald L | Veterinary liniment and method |
US5116620A (en) * | 1989-11-21 | 1992-05-26 | Bruce A. Barber | Antimicrobial wound dressing |
US5227168A (en) * | 1989-11-21 | 1993-07-13 | Bruce Barber | Method of treating a wound |
US5104660A (en) * | 1989-11-21 | 1992-04-14 | Bruce A. Barber | Method of preparing an antimicrobial wound dressing |
US5714232A (en) * | 1991-05-01 | 1998-02-03 | E. R. Squibb & Sons, Inc. | Alginate fabric, its use in wound dressings and surgical haemostats and a process for its manufacture |
IL147222A0 (en) * | 1999-06-25 | 2002-08-14 | Abiogen Pharma Spa | Preparation and metering of components with co2 |
US6333054B1 (en) | 1999-10-21 | 2001-12-25 | Amuchina S.P.A. | Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
DE10051983A1 (de) * | 2000-10-20 | 2002-06-13 | Beate Kehrel | Inhibierung der pathogenen Wirkung oxidierter Proteine |
FR2819723B1 (fr) * | 2001-01-23 | 2006-11-17 | Arnaud Mainnemare | Composition halogene, son procede de preparation et ses utilisations |
US20050282895A1 (en) * | 2004-06-21 | 2005-12-22 | Dosch Michael H | Antimicrobial compositions and methods of use thereof |
US7410661B2 (en) * | 2004-08-02 | 2008-08-12 | Weston Haskell | Enhanced wound healing method, product and composition |
US7175860B2 (en) * | 2004-08-02 | 2007-02-13 | Haskell Pharmaceuticals, Inc. | Enhanced wound healing method and composition |
US20060241002A1 (en) * | 2005-04-26 | 2006-10-26 | Rogozinski Wallace J | Sodium hypochlorite gel composition |
DK2381969T3 (en) * | 2009-01-27 | 2016-09-05 | Reddress Ltd | METHODS OF MAKING wound dressings AND A BANK wound dressings |
-
1975
- 1975-08-06 US US05/602,410 patent/US4035483A/en not_active Expired - Lifetime
-
1976
- 1976-08-04 CA CA258,436A patent/CA1067408A/en not_active Expired
- 1976-08-05 GB GB32745/76A patent/GB1552641A/en not_active Expired
- 1976-08-05 SE SE7608812A patent/SE7608812L/xx unknown
- 1976-08-05 JP JP51093555A patent/JPS5234916A/ja active Pending
- 1976-08-05 ZA ZA764715A patent/ZA764715B/xx unknown
- 1976-08-05 BE BE169574A patent/BE844904A/xx not_active IP Right Cessation
- 1976-08-06 AT AT585676A patent/AT355223B/de not_active IP Right Cessation
- 1976-08-06 NL NL7608809A patent/NL7608809A/xx not_active Application Discontinuation
- 1976-08-06 FR FR7624176A patent/FR2320110A2/fr active Granted
- 1976-08-06 DE DE19762635508 patent/DE2635508A1/de not_active Withdrawn
- 1976-08-06 IE IE1752/76A patent/IE43853B1/en unknown
- 1976-08-06 DK DK354776A patent/DK143690C/da active
- 1976-08-06 AU AU16667/76A patent/AU502926B2/en not_active Expired
- 1976-08-06 LU LU75563A patent/LU75563A1/xx unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4204992A (en) | 1977-08-29 | 1980-05-27 | Avicon, Inc. | Method for preparing pyrogen free collagen |
US4363322A (en) | 1978-04-13 | 1982-12-14 | Andersson A E Bror | Deodorizing and disinfecting liquid-absorbing product and process for production thereof |
WO1984001108A1 (en) * | 1982-09-14 | 1984-03-29 | Magnus Hoeoek | Means for removing microorganisms from tissue |
Also Published As
Publication number | Publication date |
---|---|
FR2320110B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1979-06-29 |
FR2320110A2 (fr) | 1977-03-04 |
SE7608812L (sv) | 1977-02-07 |
JPS5234916A (en) | 1977-03-17 |
NL7608809A (nl) | 1977-02-08 |
BE844904A (fr) | 1977-02-07 |
DK354776A (da) | 1977-02-07 |
AU502926B2 (en) | 1979-08-16 |
ATA585676A (de) | 1979-07-15 |
ZA764715B (en) | 1977-07-27 |
IE43853B1 (en) | 1981-06-17 |
AU1666776A (en) | 1978-02-09 |
DK143690B (da) | 1981-09-28 |
AT355223B (de) | 1980-02-25 |
LU75563A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-03-28 |
IE43853L (en) | 1977-02-06 |
CA1067408A (en) | 1979-12-04 |
DK143690C (da) | 1982-03-22 |
GB1552641A (en) | 1979-09-19 |
US4035483A (en) | 1977-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2635508A1 (de) | Antiseptischer verband | |
AT393795B (de) | Kohaerentes, poroeses kollagenfolienmaterial und verfahren zu seiner herstellung | |
DE60008790T3 (de) | Medizinische verbände enthaltend gelartigen honig | |
DE2943520C2 (de) | Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke | |
DE19851334C2 (de) | Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung | |
EP1593399B1 (de) | Bioresorbierbare Wundauflage auf Kollagen-Basis | |
DE3034273A1 (de) | Regeneriertes kollagen und verfahren zu dessen herstellung | |
DE2918098A1 (de) | Haemostatisches mittel, verfahren zu seiner herstellung und seine verwendung zur kontrolle doer stillung einer blutung | |
CH637833A5 (de) | Transparentes fluessigkeitsverbandmaterial, seine herstellung und verwendung. | |
DE3011664A1 (de) | Wundverband | |
DE3135410A1 (de) | Kleimtoetender absorbierender koerper | |
WO1981000963A1 (en) | Process for preparing a collagen product for medical and cosmetic use | |
DE2305998A1 (de) | Neue desodorierende damenbinden auf der grundlage von perjodsaeure | |
DE2849570C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE1642578B2 (de) | Verfahren zur Herstellung einer enzymatischen Zusammensetzung mit proteolytischem Enzym und Kollagenase-Aktivität | |
DE2823620A1 (de) | Kollagen-hautverbandsmaterial | |
CH615099A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
DE69231916T2 (de) | Makroskopisch orientiertes zelladhäsionsprotein zur wundbehandlung | |
DE2945420C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
CH279767A (de) | Verband. | |
DE69105077T2 (de) | Verwendung von Polysacchariden in Zubereitungen zur Wundbehandlung. | |
DE2327687A1 (de) | Antiseptisches mittel | |
DE60205906T2 (de) | Poröses schwammartiges Cellulosematerial zur Behandlung von Verletzungen | |
DE2600498A1 (de) | Loesung fuer die hautbehandlung und mit dieser loesung hergestellte nasswindel | |
DE2348685A1 (de) | Therapeutisches faservlies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OGA | New person/name/address of the applicant | ||
8110 | Request for examination paragraph 44 | ||
8130 | Withdrawal |